期刊文献+

葛根素联合γ突触核蛋白-微小RNA对肺癌H1299细胞增殖凋亡的影响 被引量:1

Effect of puerarin combined with SNCG-siRNA on proliferation and apoptosis of lung cancer H1299 cells and its mechanism
下载PDF
导出
摘要 目的探讨葛根素联合γ突触核蛋白-微小RNA(SNCG-siRNA)对肺癌H1299细胞增殖、凋亡的影响及其机制。方法以0、20、40、80、160和320μg/mL葛根素作用于体外培养的H1299细胞24 h后,采用MTT法检测细胞增殖并计算出葛根素的IC50。在H1299细胞中转染SNCG干扰序列SNCG-siRNA及其阴性对照NC-siRNA后,采用逆转录-聚合酶链反应(RT-PCR)和蛋白质免疫印迹(Western blot)检测转染效果。以150μg/mL葛根素处理转染SNCG-siRNA或NC-siRNA的H1299细胞24 h后,采用MTT法、克隆形成实验和流式细胞仪分别检测细胞的增殖、克隆形成和凋亡能力,Western blot检测细胞中肿瘤增殖抗原(Ki67)、细胞周期蛋白D1(Cyclin D1)、B淋巴细胞瘤-2(Bcl-2)蛋白和Bcl-2相关X蛋白(Bax)的表达情况。结果与0μg/mL处理组相比,20、40、80、160和320μg/mL葛根素处理后H1299细胞存活率均明显降低(P<0.05),IC50为150.40μg/mL。与NCsiRNA组相比,SNCG-siRNA组细胞中SNCG mRNA和蛋白的表达水平均明显降低(P<0.05)。与NC-siRNA组相比,SNCG-siRNA、葛根素+NC-siRNA和葛根素+SNCG-siRNA处理组细胞的存活率、克隆形成率和细胞中Ki67、CyclinD1、Bcl-2蛋白的表达水平均明显降低,而细胞凋亡率和细胞中Bax蛋白的表达水平均明显升高(P<0.05),且葛根素+SNCG-siRNA处理对H1299细胞的作用强度明显大于葛根素+NC-siRNA或者SNCG-siRNA组。结论葛根素素和SNCG-siRNA联合可协同抑制H1299细胞增殖并促进细胞凋亡,其作用机制可能与共同下调Ki67、CyclinD1、Bcl-2和上调Bax蛋白的表达有关。 Objective To investigate the effect of puerarin combined with SNCG-siRNA on proliferation and apoptosis of lung cancer H1299 cells and its mechanism.Methods Puerarin(0,20,40,80,160 and 320μg/mL)was used to treat H1299 cells in vitro for24 hours.MTT method was used to detect cell proliferation and calculate the IC50 of puerarin.After transfection of SNCG interference sequence SNCG-siRNA and its negative control NC-siRNA into H1299 cells,the transfection effect was detected by RT-PCR and Western blot.The proliferation,clone formation and apoptosis of H1299 cells transfected with SNCG-siRNA or NC-siRNA were detected by MTT,clone formation test and flow cytometry after treatment with 150μg/mL puerarin for 24 hours.The expressions of Ki67,Cyclin D1,Bax and Bcl-2 protein were detected by Western blot.Results cells stimulated by 20,40,80,160 and 320μg/mL puerarin was significantly decreased(P<0.05),and the IC50 was 150.40μg/mL.Compared with NC-siRNA group,the expression levels of SNCG mRNA and protein in SNCG-siRNA group were significantly lower(P<0.05).Compared with NC-siRNA group,the cell survival rate,cloning formation rate and the expression level of Ki67,Cyclin D1 and Bcl-2 protein were reduced significantly in SNCG-siRNA,puerarin+NC-siRNA and puerarin+SNCG-siRNA treatment groups,while the apoptotic rate and the expression level of Bax protein in cells were significantly increased(P<0.05),and the effect of puerarin+SNCG-siRNA treatment on H1299 cells was stronger than that of puerarin+NC-siRNA or SNCG-siRNA.Conclusion SNCG-siRNA can synergistically inhibit the proliferation and promote apoptosis of H1299 cells.The mechanism may be related to the co-down-regulation of Ki67,Cyclin D1,Bcl-2 and up-regulation of Bax protein expression.
作者 邹华兰 曾健梅 冷兴强 钟晶宇 ZOU Hualan;ZENG Jianmei;LENG Xingqiang;ZHONG Jingyu(Department of the First Internal Medicine,Shapingba District Hospital of Traditional Chinese and Western Medicine,Chongqing 401334,China;Department of Oncology,Jiangjin District Central Hospital,Chongqing 402272,China)
出处 《安徽医药》 CAS 2021年第5期1009-1013,共5页 Anhui Medical and Pharmaceutical Journal
关键词 肺肿瘤 葛根素 γ突触核蛋白 细胞增殖 细胞凋亡 Lung neoplasms Puerarin SNCG Cell proliferation Cell apoptosis
  • 相关文献

参考文献5

二级参考文献31

  • 1LU Aiping1, LI Qing1, LIU Jingwen2 1. Department of Pathology, Peking University School of Oncology, Beijing Cancer Hospital, Beijing 100036, China,2. VA Palo alto Health Care System, Palo Alto, California, CA 94304, USA.Regulatory mechanisms for abnormal expression of the human breast cancer specific gene 1 in breast cancer cells[J].Science China(Life Sciences),2006,49(4):403-408. 被引量:8
  • 2李燕,寿成超.SNCG基因的研究进展[J].宁夏医学院学报,2004,26(5):383-386. 被引量:1
  • 3Annovazzi L, Caldera V, Mellai M, et al. The DNA damage/ repair cascade in glioblastoma cell lines after chemothera- peutic agent treatmen[J]. Int J Oncol, 2015, 46(6):2299-2308.
  • 4Jeyapalan S, Boxerman J, Donahue J, et al. Paclitaxel poli- glumex, temozolomide, and radiation for newly diagnosed high-grade glioma: a Brown University Oncology Group Study[J]. Am J Clin Oncol, 2014, 37(5):444-449.
  • 5Surgnehov A. Synueleins: are they two-edged swords[J]? J Neurosei Res, 2013, 91(2):161-166.
  • 6Surguchov A. Molecular and cellular biology of synucleins [J]. Int Rev Cell Mol Biol, 2008, 270:225-317.
  • 7Sok JC, Coppelli FM, Thomas SM, et al. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting[J]. Clin Cancer Res, 2006, 12(17):5064-5073.
  • 8Singh VK, Jia Z. Targeting synucMn-gamma to counteract drug resistance in cancer[J]. Expert Opin Ther Targets, 2008, 12(1):59-68.
  • 9Ninkina NN, Alimova-Kost MV, Paterson JW, et al. Organi- zation, expression and polymorphism of the human persyn gene[J]. Hum Mol Genet, 1998, 7(9):1417-1424.
  • 10Mollinedo F, Gajate C. Microtubules, microtubule-interfer- ing agents and apoptosis[J]. Apoptosis, 2003, 8(5):413-450.

共引文献9

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部